BI seeks local partners to life market share

By Ding Yining | July 30, 2015, Thursday |

Online Edition

GERMAN pharmaceutical company Boehringer Ingelheim said it is seeking more partnership with local pharmaceutical companies to lift its market share in the consumer health sector, a company senior executive said yesterday.

The company yesterday co-launched an anti-constipation traditional Chinese non-prescription drug DulcoTong through collaboration with Henan-based Furen Medicines Group. The new product will be a compliment to Boehringer Ingelheim's existing Duocolax tablet and also marks the first time the German company owns a proprietary brand and officially enters the traditional Chinese medicine market.

Boehringer Ingelheim will oversee the marketing and distribution of DulcoTong in China's mainland and Furen will be responsible for the production.

Currently consumer healthcare and over-the-counter drugs(OTC) accounts for 11 percent of Boehringer Ingelheim's overall sales. "We're actively seeking partnerships or potential acquisition target to lift its foothold in the OTC segment," said president and chief executive officer of Boehringer Ingelheim China David Preston.

Business Boehringer Ingelheim

About Us
|
Terms of Use
|
RSS
|
Privacy Policy
|
Contact Us
|
Shanghai Call Center: 962288
|
Tip-off hotline: 52920043

沪ICP证：沪ICP备05050403号-1
|
互联网新闻信息服务许可证：31120180004
|
网络视听许可证：0909346
|
广播电视节目制作许可证：沪字第354号
|
增值电信业务经营许可证：沪B2-20120012

BI seeks local partners to life market share

Email this to your friend